BlueLinx Announces Third Quarter 2018 Results
– Net Sales of $860 million for the Quarter; Up $380 million From Q3 2017– Gross Profit of $92 million […]
Mechel Reports Launch of New Longwall at Southern Kuzbass
MOSCOW, Nov. 08, 2018 (GLOBE NEWSWIRE) — Mechel PAO (MOEX: MTLR, NYSE: MTL), one of the leading Russian mining and […]
Canada House Clinics Partners with Peak Pharma Solutions for Patient Growth
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 08, 2018 (GLOBE NEWSWIRE) — […]
ePlay Announces New Competitive Challenge Features to Big Shot Basketball App
Big Shot Basketball Beta iPhone app updated with new features and available in Apple App Store. CALGARY, Alberta, Nov. 08, […]
LiteLink Technologies Joins Blockchain in Transport Alliance
VANCOUVER, British Columbia, Nov. 08, 2018 (GLOBE NEWSWIRE) — LiteLink Technologies Inc. (“LiteLink”) (CSE:LLT) (FRA:C0B) (litelinktech.com), a leading blockchain enterprise […]
Capricor Therapeutics to Present Corporate Overview and Poster at Action Duchenne International Conference
Research Found Exosomes Increased Exercise Capabilities and Muscle Activity in a Mouse Model of Duchenne Muscular Dystrophy LOS ANGELES, Nov. […]
Windstream reports third-quarter results
Grew broadband customer base for second consecutive quarterContinued acceleration in SD-WAN and Enterprise strategic salesDelivered third consecutive quarter of Adjusted […]
ContraFect Announces Third Quarter 2018 Financial Results
YONKERS, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and […]
Opera Limited announces third quarter 2018 financial results and initiation of share repurchase program
Revenue of $44.7 million, with 56.8% year-over-year growth of advertising revenue All-time-high operating profit, net income, adjusted EBITDA and adjusted […]
Assembly Biosciences Announces Third Quarter 2018 Financial Results and Provides HBV Program Update
ABI-H0731 Phase 2a Clinical Trials Actively Enrolling Patients; Data Continues to be Anticipated in 1H 2019 ABI-H2158 Phase 1a Study […]
